NASDAQ:OTLK - Nasdaq - US69012T3059 - Common Stock - Currency: USD
Overall OTLK gets a fundamental rating of 1 out of 10. We evaluated OTLK against 549 industry peers in the Biotechnology industry. Both the profitability and financial health of OTLK have multiple concerns. OTLK is valued correctly, but it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 108.58% | ||
ROE | N/A | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | N/A | ||
Altman-Z | -54.53 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.72 | ||
Quick Ratio | 0.57 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.08 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
2.77
+0.43 (+18.38%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.08 | ||
Fwd PE | N/A | ||
P/S | N/A | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 108.58% | ||
ROE | N/A | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.72 | ||
Quick Ratio | 0.57 | ||
Altman-Z | -54.53 |